ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Embecta Corporation

Embecta Corporation (EMBC)

14.00
0.39
(2.87%)
종가: 22 11월 6:00AM
14.00
0.01
( 0.07% )
시간외 거래: 6:03AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
14.00
매수가
13.73
매도가
14.84
거래량
229,029
13.67 일간 변동폭 14.20
9.925 52주 범위 19.79
market_cap
전일 종가
13.61
개장가
13.67
최근 거래 시간
1
@
14
마지막 거래 시간
06:20:41
재정 규모
US$ 3,196,518
VWAP
13.9568
평균 볼륨(3m)
362,737
발행 주식
57,701,830
배당수익률
4.29%
주가수익률
11.47
주당순이익(EPS)
1.22
매출
1.12B
순이익
70.4M

Embecta Corporation 정보

Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others. Embecta Corp is a medical technology company. The company develops innovative technology, services, and solutions that help advance both clinical therapy for patients and clinical processes for healthcare providers. Its products include BD Pyxis, PureWick, Phasix among others.

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Embecta Corporation is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker EMBC. The last closing price for Embecta was US$13.61. Over the last year, Embecta shares have traded in a share price range of US$ 9.925 to US$ 19.79.

Embecta currently has 57,701,830 shares in issue. The market capitalisation of Embecta is US$785.32 million. Embecta has a price to earnings ratio (PE ratio) of 11.47.

EMBC 최신 뉴스

UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results

PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference...

embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell

PARSIPPANY, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, announced it will ring the Nasdaq Closing Bell today in recognition...

embecta Announces FDA Clearance of its Disposable Patch Pump for Insulin Delivery Informed by the Unique Needs of People with Type 2 Diabetes

While 9 out of 10 people with diabetes are living with T2D, many of the automated insulin delivery solutions currently on the market were designed for people living with T1D.300-unit insulin...

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that...

Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and...

embecta Announces Quarterly Cash Dividend

PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-1.555-9.9967855994915.55515.6413.0537628414.029243CS
4-0.05-0.35587188612114.0516.3713.0527944114.78711928CS
12-1.47-9.5022624434415.4717.0512.4236273714.83692959CS
260.070.50251256281413.9317.3311.4637488014.14946752CS
52-2.02-12.609238451916.0219.799.92541931714.67605926CS
156-18.36-56.736711990132.3636.649.92562225823.72368095CS
260-18.36-56.736711990132.3636.649.92562225823.72368095CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
MTEMMolecular Templates Inc
US$ 0.605
(59.21%)
8.37M
VRPXVirpax Pharmaceuticals Inc
US$ 0.84
(44.28%)
2.63M
SKKSKK Holdings Limited
US$ 1.27
(25.74%)
3.05M
REPLReplimune Group Inc
US$ 13.20
(19.24%)
58.93k
MSTXTidal Trust II Defiance Daily Target 2x Long MSTR ETF
US$ 137.12
(15.76%)
303.99k
CETXCemtrex Inc
US$ 0.16
(-17.27%)
533.07k
SPRCSciSparc Ltd
US$ 0.245
(-15.22%)
160.25k
LGTYLogility Supply Chain Solutions Inc
US$ 9.84
(-11.99%)
4.09k
MODDModular Medical Inc
US$ 1.71
(-11.86%)
101.57k
CNTXContext Therapeutics Inc
US$ 1.3499
(-10.01%)
9.33k
MTEMMolecular Templates Inc
US$ 0.605
(59.21%)
8.37M
CDTConduit Pharmaceuticals Inc
US$ 0.0967
(-7.73%)
4.08M
ELABElevai Labs Inc
US$ 0.02
(-0.36%)
3.51M
SKKSKK Holdings Limited
US$ 1.27
(25.74%)
3.05M
VRPXVirpax Pharmaceuticals Inc
US$ 0.84
(44.28%)
2.63M